That’s the opinion of Stephen Salzburg, the special master in the Yaz litigation. Keystone Progress reported the following on July 6th:
"So far, so good," he said of the status of the litigation. "I am cautiously optimistic that we will settle all of these cases. There are always some holdouts, but I think we will settle the bulk of these cases in the next year."
The article also reports that over 1,500 Yaz lawsuits have been settled so far for an average value of $214,000. Of course, that’s an average, and “some of the more serious cases may get more while others might get less.”
The more serious cases include those cases in which a woman developed a DVT, suffered a pulmonary embolism, or had a stroke or heart attack related to a blood clot. Salzburg notes that even though it’s the “most serious” cases that are currently settling, “the rest will go fairly quickly.”
At this point, we believe that any woman who suffered a serious pulmonary event such as a DVT or embolism while taking Yaz may be eligible for a Yaz settlement. Contact us today if you’d like more information.
Comments